Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/37338
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkbudak, İsmail Hakkı-
dc.date.accessioned2021-02-02T09:25:17Z-
dc.date.available2021-02-02T09:25:17Z-
dc.date.issued2020-
dc.identifier.issn2717-6428-
dc.identifier.urihttps://hdl.handle.net/11499/37338-
dc.identifier.urihttps://doi.org/10.37678/dcybd.2020.2349-
dc.description.abstractCorticosteroid therapy has been used for many years and is still controversial in use. In the Coronovirus disease 2019 (COVID-19) outbreak, it is very important to find reliable treatment information for clinicians and patients. Low dose corticosteroids are also used in patients with septic shock, relative adrenal insufficiency and acute respiratory distress syndrome (ARDS). There is not enough evidence for its use in COVID-19. However, low dose use is recommended in the case of ARDS and septic shock in COVID-19 patients. Caution should be exercised until further evidence emerges surrounding the use of corticosteroids in COVID-19 patients. © 2020 by Turkish Society of Medical and Surgical Intensive Care Medicine.en_US
dc.language.isoenen_US
dc.publisherTurkish Society of Medical and Surgical Intensive Careen_US
dc.relation.ispartofJournal of Critical and Intensive Careen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectCorticosteroidsen_US
dc.subjectRespiratory Failureen_US
dc.subjectSeptic Shocken_US
dc.subjectcorticosteroiden_US
dc.subjectglucocorticoiden_US
dc.subjecthydrocortisoneen_US
dc.subjectmethylprednisoloneen_US
dc.subjectadrenal insufficiencyen_US
dc.subjectadult respiratory distress syndromeen_US
dc.subjectartificial ventilationen_US
dc.subjectclinicianen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectcorticosteroid therapyen_US
dc.subjectdisease severityen_US
dc.subjecthumanen_US
dc.subjecthyperglycemiaen_US
dc.subjecthypernatremiaen_US
dc.subjecthypokalemiaen_US
dc.subjectlength of stayen_US
dc.subjectlow drug doseen_US
dc.subjectpregnant womanen_US
dc.subjectReviewen_US
dc.subjectrisk factoren_US
dc.subjectsecondary infectionen_US
dc.subjectseptic shocken_US
dc.subjectviral clearanceen_US
dc.titleCorticosteroid therapy in COVID-19 diseaseen_US
dc.typeReviewen_US
dc.identifier.volume11en_US
dc.identifier.startpage30-
dc.identifier.startpage30en_US
dc.identifier.endpage31en_US
dc.authorid0000-0002-3716-9243-
dc.identifier.doi10.37678/dcybd.2020.2349-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.scopus2-s2.0-85090099105en_US
dc.identifier.trdizinid384182en_US
dc.identifier.wosWOS:000614479400010en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale University-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypeReview-
item.grantfulltextopen-
crisitem.author.deptPamukkale Üniversitesi-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File SizeFormat 
fd160767-0d22-4eff-b954-2c50a9316c35.pdf96.29 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

Page view(s)

48
checked on Aug 24, 2024

Download(s)

28
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.